CME: The Atopic Dermatitis Horizon: A Look at Newer Mechanisms & Treatment Options

Be part of the knowledge.

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

The Atopic Dermatitis Horizon: A Look at Newer Mechanisms & Treatment Options

Program Information
The Atopic Dermatitis Horizon: A Look at Newer Mechanisms & Treatment Options
There are two new disease mechanism-targeted treatments for atopic dermatitis, but how do you know when to use each one?

Available credits: 0.50

Time to complete: 30 Minutes


Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    Crisaborole and dupilumab are two of the newest therapies to become part of the atopic dermatitis treatment landscape, so here to provide guidance on how we can apply them—and even how they may lead the way to more targeted treatments in the future—are allergist Dr. Anna Fishbein and dermatologist Dr. Lindsay Strowd.

  • Learning Objectives

    • Choose appropriate AD therapy on the basis of mechanism and key clinical trial data
  • Target Audience

    The primary audience who will use and benefit from this educational initiative includes dermatologists, allergists, nurse practitioners, physician assistants, and nurses who manage patients of all ages with Atopic Dermatitis.

  • Disclosure of Conflicts of Interest

    Anna Fishbein, MD, has nothing to disclose.
    Lindsay C. Strowd, MD, FAAD, has done contract research for Pfizer, Inc.

  • Accreditation and Credit Designation Statements

    The France Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The France Foundation designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)

  • Commercial Support

    This activity is supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals. 

  • Terms of Use

    TFF requires CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental, and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of U.S. Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. TFF does not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.


    Technical Requirements:

    1. There are no fees for participating in and receiving credit for this activity.
    2. Review the activity objectives and CME/CE information.
    3. Complete the CME/CE activity
    4. Complete the online posttest. A score of at least 75% is required to successfully complete this activity. The participant may take the test until successfully passed.
    5. Complete the CME/CE evaluation/attestation form, which provides each participant with the opportunity to comment on how participating in the activity will affect their professional practice, the quality of the instructional process, the perception of enhanced professional effectiveness, the perception of commercial bias, and his/her views on future educational needs.
    6. Credit documentation/reporting:

    If you are requesting AMA PRA Category 1 Credits™ or a certificate of participation—your CME/CE certificate will be available for download.

  • Disclaimer

    The France Foundation presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation and the commercial supporter(s) assume no liability for the information herein.

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio


Programs 11/19/19

    Get a Dose of ReachMD in Your Inbox
    and Practice Smarter Medicine

    Stay current with the best in medical education.